Our data illustrating an accumulation of β-catenin upon a reduction of WT1 in leukemic cells corresponds to an observed negative impact of WT1 on β-catenin signaling in breast cancer cells [51], Sertoli cells forming the blood-testis barrier [50], and podocytes within the kidney [52]. This evidence concerns the gene WT1 and breast cancer.